# Letrozole in Induction of Abortion of Anembryonic Pregnancy

> **NCT05198050** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 96 (actual)

## Conditions studied

- Anembryonic Pregnancy

## Interventions

- **DRUG:** Letrozole tablets
- **DRUG:** Misoprostol Tabets
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT05198050
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-03
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198050, "Letrozole in Induction of Abortion of Anembryonic Pregnancy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05198050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*